Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery
NCT06575049
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Post-Operative Hematoma
Seroma as Procedural Complication
Post-Op Complication
Sponsor
Seoul National University Hospital